Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Heron Therapeutics, Inc.    HRTX

HERON THERAPEUTICS, INC.

(HRTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector news

HERON THERAPEUTICS, INC. /DE/ : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
09/16/2020 | 08:42am EDT

Item 7.01 Regulation FD Disclosure.

On September 16, 2020, Heron Therapeutics, Inc. issued a press release announcing that the results from EPOCH 2 follow-on study (NCT03695367) of the investigational agent HTX-011 in open inguinal hernia repair surgery with mesh, have been published online by the journal, Surgery in an article entitled "Opioid-free recovery following herniorrhaphy with HTX-011 as the foundation of a multimodal analgesic regimen," as described in the press release furnished herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.



Exhibit No.   Description

99.1            Press Release, dated September 16, 2020
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
All news about HERON THERAPEUTICS, INC.
09/17HERON THERAPEUTICS : Announces Publication of Results from EPOCH 2 Follow-On Stu..
AQ
09/16HERON THERAPEUTICS, INC. /DE/ : Regulation FD Disclosure, Financial Statements a..
AQ
09/14HERON THERAPEUTICS : to Present at Cantor Virtual Global Healthcare Conference
AQ
09/09HERON THERAPEUTICS : Announces Successful Outcome of FDA Type A Meeting to Discu..
AQ
09/08HERON THERAPEUTICS, INC. /DE/ : Other Events, Financial Statements and Exhibits ..
AQ
08/05HERON THERAPEUTICS : 2Q Earnings Snapshot
AQ
08/05HERON THERAPEUTICS, INC. /DE/ : Change in Directors or Principal Officers (form ..
AQ
08/05HERON THERAPEUTICS : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
08/05HERON THERAPEUTICS, INC. /DE/ : Results of Operations and Financial Condition, F..
AQ
07/27HERON THERAPEUTICS : Receives Positive CHMP Opinion for ZYNRELEF for the Managem..
AQ
More news